We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Warned for Minimizing Seroquel Health Risks
AstraZeneca Warned for Minimizing Seroquel Health Risks
November 27, 2006
The FDA has instructed AstraZeneca to stop distributing a professional sales aid for its antipsychotic Seroquel because it lacks appropriate risk information for the drug, according to an agency warning letter.